Georgia's Online Cancer Information Center

Georgia NCI Community Oncology Research Program

GeorgiaNCORP

A novel research program puts cutting-edge treatments and studies within reach of more Georgians

THE PROBLEM: For cancer care to improve in our state, more Georgians must be able to participate in promising new treatments or studies that help prevent and control cancer.

Such programs are typically offered in cancer centers in high-populated areas; so historically, they’ve been out of reach to many Georgians. And in places where they were offered, many under-served populations weren’t aware they existed. Until now.

THE PROGRAM: GA NCORP is part of a larger national effort developed by the National Cancer Institute, or NCI.

Started in 2014, Georgia NCORP is a collaboration between Georgia CORE, Northside Hospital Cancer Institute in Atlanta, and the Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph’s/Candler in Savannah. From 2014-2018, approximately 30,000 patients nationwide were enrolled in NCI clinical trials through the NCORP sites. After a successful first five years, the statewide cancer research consortium has been awarded an $11 million, six-year renewal grant for cancer research.

Georgia CORE oordinates the participation of network affiliates — John B. Amos Cancer Center in Columbus; Harbin Clinic in Rome; Peyton Anderson Cancer Center Navicent Health in Macon; Cancer Services at Northeast Georgia Medical Center in Gainesville; and Pearlman Cancer Center at South Georgia Medical Center in Valdosta.

THE GOALS

1. Get more eligible Georgians to participate in cancer clinical trials in their own communities by increasing awareness of treatment options

2. Reduce cancer care disparities by enrolling more underrepresented populations of Georgians in all kinds of studies and settings

3. Balance the portfolio of research among open studies for treatment and cancer prevention and control studies

4. Get more healthcare providers in Georgia CORE’s network to participate in GA NCORP careand research

THE REACH

So far, GA NCORP is creating a constellation of participation in cutting-edge studies and treatments.

In the program’s seventh year, 3 out of 4 Georgians are within reach of new prevention, control, and treatment trials. Many are in rural and underserved communities.

THE ADDED BENEFIT

Physicians and scientists conducting studies need broad populations to participate, so that results will be more precise and beneficial. By engaging Georgians from all geographic areas and backgrounds, GA NCORP makes the work of these researchers more relevant and valuable.

THE IMPACT

GA NCORP has:

  • Built a network of 100 physicians with access to dozens of studies – in treatment, prevention and control – available in 41 locations across the state
  • Far exceeded national averages in the percentage of rural residents and racial/ethnic minorities enrolled in clinical treatments and other studies
  • Ranked in the top quartile nationally for achieving goals
  • Opened and recruited participants in five new studies in cancer care delivery research
  • Developed and presented a new concept for genomics research
  • Ranked in the top 15 sites nationally for enrolling patients in 11 high-priority clinical trials
  • Received NCI’s Platinum Certificate of Excellence Award for exceptional achievement in enrolling patients in trials

Because of GA NCORP, nearly 2,650 more Georgians have participated in new clinical treatments and other studies – all approved by the National Cancer Institute, and 25 percent were minorities.

NETWORK PARTNERS & MEMBERS

Research

Georgia Distinguished Cancer Scholars Summit a Success

On May 9, Georgia’s Distinguished Cancer Scholars gathered for the first time since the program was discontinued more than a decade ago.

5/26/2022

Four multinational, interdisciplinary teams selected to address major challenges in cancer

The research being conducted by the four selected teams includes investigation of 1) a muscle-wasting condition in cancer patients known as cachexia, 2) the biology of extrachromosomal DNA in cancer 3) new therapies for solid tumors in children, and 4) what triggers normal cells harboring cancer-causing mutations to become tumor cells.

6/28/2022

Georgia CORE's FY22 Annual Report

Click above, then for optimal viewing, hit the Fullscreen icon in the bottom right corner.

11/15/2022

 About

Disparities in Cancer Clinical Trials Summit

On Sept. 30, Georgia's cancer experts shared advice and experiences with oncology providers, patient navigators and research managers - all to provide new ways to diversify participation in clinical trials. See scenes from the summit >>

10/25/2022

Research Trials Saves Lives

Lynn Durham shares her cancer journey on the podcast, Kickin' it Forward.

3/14/2022

Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.